<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">spbmedicalrecords</journal-id><journal-title-group><journal-title xml:lang="ru">Новые Санкт-Петербургские врачебные ведомости</journal-title><trans-title-group xml:lang="en"><trans-title>New St. Petersburg Medical Records</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-2201</issn><publisher><publisher-name>Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1609-2201-2025-104-2-55-66</article-id><article-id custom-type="elpub" pub-id-type="custom">spbmedicalrecords-100</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ СЛУЧАИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Клинический случай наследственного транстиретинового амилоидоза с преимущественным поражением сердца</article-title><trans-title-group xml:lang="en"><trans-title>Clinical case of hereditary transthyretin amyloidosis with predominant heart involvement</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5659-4731</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyeva</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воробьева Снежана Викторовна, врач-терапевт терапевтического отделения №3 клиники НИИ нефрологии клиники научно-клинического исследовательского центра</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6–8</p></bio><bio xml:lang="en"><p>Snezhana V. Vorobyeva, physician of the therapeutic department 3 of the Clinic of the research Institute of Nephrology of the Clinic of the Clinical research Center</p><p>6–8, L’va Tolstogo str., Saint Petersburg, 197022</p></bio><email xlink:type="simple">blaze04@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-6854-5354</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Молоковских</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Molokovskikh</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Молоковских Станислава Витальевна, врач-терапевт терапевтического отделения №3 клиники НИИ нефрологии клиники научно-клинического исследовательского центра</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Stanislava V. Molokovskikh, physician of the therapeutic department 3 of the Clinic of the research Institute of Nephrology of the Clinic of the Clinical research Center</p><p>Saint Petersburg</p></bio><email xlink:type="simple">Dr.molokovskikh@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-2796-8755</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чапля</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Chaplya</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чапля Владислава Олеговна, клинический ординатор по специальности «Терапия» кафедрыпропедевтики внутренних болезней с клиникой имени академика М. Д. Тушинского</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Vladislava O. Chaplya, resident of Department of Propaedeutics of Internal Diseases with clinic named after acad. M. D. Tushinksy</p><p>Saint Petersburg</p></bio><email xlink:type="simple">chaplya_vo@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4631-2766</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьева</surname><given-names>Н. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoreva</surname><given-names>N. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Григорьева Наталья Дмитриевна, кандидат медицинских наук, заведующая отделением, врач-терапевт терапевтического отделения №3 клиники НИИ нефрологии клиники научно-клинического исследовательского центра</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Natalia D. Grigoreva, Cand. of Sci. (Med.), head of the therapeutic department 3 of the Clinic of the research Institute of Nephrology of the Clinic of the Clinical research Center</p><p>Saint Petersburg</p></bio><email xlink:type="simple">lucas69@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4544-2967</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куликов Александр Николаевич, доктор медицинских наук, профессор, заведующий кафедрой пропедевтики внутренних болезней с клиникой имени академика М. Д. Тушинского, заведующий кафедрой функциональной диагностики, директор научно-клинического исследовательского центра</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Alexander N. Kulikov, Dr. of Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal Diseases with clinic named after acad. M. D. Tushinksy, Head of the Department of Functional Diagnostics, Director of the Scientific and Clinical Research Center</p><p>Saint Petersburg</p></bio><email xlink:type="simple">ankulikov2005@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Боровская</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Borovskaya</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Боровская Елена Анатольевна, заведующая отделением функциональной диагностики, кандидат медицинских наук, доцент кафедры функциональной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Elena A. Borovskaya, Head of the Functional Diagnostics Department, Cand. of Sci. (Med.), Associate Professor of the Functional Diagnostics Department</p><p>Saint Petersburg</p></bio><email xlink:type="simple">e.a.borovskaya@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Владимирова</surname><given-names>Ю. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Vladimirova</surname><given-names>Yu. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимирова Юлия Федоровна, врач функциональной диагностики, кандидат медицинских наук, ассистент кафедры функциональной диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Yulia F. Vladimirova, Doctor of Functional Diagnostics,Cand. of Sci. (Med.), Assistant Professor, Department of Functional Diagnostics</p><p>Saint Petersburg</p></bio><email xlink:type="simple">Juliyavladimirova@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кириллова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirillova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кириллова Елена Владимировна, врач ультразвуковой диагностики</p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Elena V. Kirillova, ultrasound diagnostics physician</p><p>Saint Petersburg</p></bio><email xlink:type="simple">ekirillova78@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова<country>Россия</country></aff><aff xml:lang="en">Pavlov University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Первый Санкт-Петербургский государственный&#13;
медицинский университет имени академика И. П. Павлова<country>Россия</country></aff><aff xml:lang="en">Pavlov University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2025</year></pub-date><volume>0</volume><issue>2</issue><fpage>55</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воробьева С.В., Молоковских С.В., Чапля В.О., Григорьева Н.Д., Куликов А.Н., Боровская Е.А., Владимирова Ю.Ф., Кириллова Е.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Воробьева С.В., Молоковских С.В., Чапля В.О., Григорьева Н.Д., Куликов А.Н., Боровская Е.А., Владимирова Ю.Ф., Кириллова Е.В.</copyright-holder><copyright-holder xml:lang="en">Vorobyeva S.V., Molokovskikh S.V., Chaplya V.O., Grigoreva N.D., Kulikov A.N., Borovskaya E.A., Vladimirova Y.F., Kirillova E.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.docved.ru/jour/article/view/100">https://www.docved.ru/jour/article/view/100</self-uri><abstract><p>Транстиретиновый амилоидоз (ATTR) с преимущественным поражением сердца быстро приводит к развитию тяжелой сердечной недостаточности. Заболевание нередко встречается у пожилых пациентов и воспринимается как часть коморбидной патологии, поэтому часто диагностируется на поздних стадиях. Целью данной публикации является демонстрация уникального клинического случая наследственного транстиретинового амилоидоза с неинвазивной верификацией диагноза, безопасной и относительно доступной по сравнению с биопсией миокарда. Ранняя диагностика амилоидной кардиомиопатии позволяет своевременно начать патогенетическую терапию.</p></abstract><trans-abstract xml:lang="en"><p>Transthyretin amyloidosis (ATTR) with predominant cardiac involvement rapidly leads to severe heart failure. The disease is not uncommon in elderly patients and is perceived as part of a comorbid pathology, so it is often diagnosed at late stages. The purpose of this publication is to demonstrate a unique clinical case of hereditary transthyretin amyloidosis with non-invasive verification of the diagnosis, safe and relatively accessible compared to myocardial biopsy. Early diagnosis of amyloid cardiomyopathy allows timely initiation of pathogenetic therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>наследственный транстиретиновый амилоидоз</kwd><kwd>амилоидная кардиомиопатия</kwd><kwd>гипертрофия левого желудочка</kwd><kwd>сердечная недостаточность</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hereditary transthyretin amyloidosis</kwd><kwd>transthyretin amyloid cardiomyopathy</kwd><kwd>left ventricular hypertrophy</kwd><kwd>chronic heart failure</kwd><kwd>case report</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">González-López E., Gallego-Delgado M., Guzzo-Merello G. et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction // Eur Heart J. 2015. Vol. 36, № 38. P. 2585–94. https://doi.org/10.1093/eurheartj/ehv338. PMID: 26224076.</mixed-citation><mixed-citation xml:lang="en">González-López E., Gallego-Delgado M., Guzzo-Merello G. et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36(38):2585–94. https://doi.org/10.1093/eurheartj/ehv338. PMID: 26224076.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bennani Smires Y., Victor G., Ribes D. et al. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy // Int J Cardiovasc Imaging. 2016. Vol. 32, № 9. P. 1403–1413. https://doi.org/10.1007/s10554-016-0915-z. PMID: 27240600</mixed-citation><mixed-citation xml:lang="en">Bennani Smires Y., Victor G., Ribes D. et al. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. Int J Cardiovasc Imaging. 2016;32(9):1403– 1413. https://doi.org/10.1007/s10554-016-0915-z. PMID: 27240600</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Никифорова Т. В., Чарая К. В., Щекочихин Д. Ю. и др. Первые данные о распространенности транстиретинового амилоидоза при гипертрофии левого желудочка в России // Кардиология. 2024. Т. 64, № 4. С. 54–60. https://doi.org/10.18087/cardio.2024.4.n2611.</mixed-citation><mixed-citation xml:lang="en">Nikiforova T. V., Charaya K. V., Shchekochikhin D. Yu. et al. First data on the prevalence of transthyretin amyloidosis in left ventricular hypertrophy in Russia. Cardiology. 2024;64(4):54–60. (In Russ.). https://doi.org/10.18087/cardio.2024.4.n2611.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ruberg F. L., Maurer M. S. Cardiac Amyloidosis Due to Transthyretin Protein: A Review. JAMA. 2024. Vol. 331, № 9. P. 778–791.</mixed-citation><mixed-citation xml:lang="en">Ruberg F. L., Maurer M. S. Cardiac Amyloidosis Due to Transthyretin Protein: A Review. JAMA. 2024;331(9):778–791.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gowda S. N., Ali H. J., Hussain I. Overview of Restrictive Cardiomyopathies // Methodist Debakey Cardiovasc J. 2022. Vol. 18, № 2. P. 4–16. https://doi.org/10.14797/mdcvj.1078. PMID: 35414858; PMCID: PMC8932380.</mixed-citation><mixed-citation xml:lang="en">Gowda S. N., Ali H. J., Hussain I. Overview of Restrictive Cardiomyopathies. Methodist Debakey Cardiovasc J. 2022;18(2):4– 16. https://doi.org/10.14797/mdcvj.1078. PMID: 35414858; PMCID: PMC8932380.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Pavia P., Rapezzi C., Adler Y. et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases // Eur Heart J. 2021. Vol. 42, № 16. P. 1554–1568. https://doi.org/10.1093/eurheartj/ehab072. PMID: 33825853; PMCID: PMC8060056.</mixed-citation><mixed-citation xml:lang="en">Garcia-Pavia P., Rapezzi C., Adler Y. et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021;42(16):1554–1568. https://doi.org/10.1093/eurheartj/ehab072. PMID: 33825853; PMCID: PMC8060056.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Poli L., Labella B., Cotti Piccinelli S. et al. Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy // Front Neurol. 2023. Vol. 14. P. 1242815. https://doi.org/10.3389/fneur.2023.1242815. PMID: 37869146; PMCID: PMC10585157.</mixed-citation><mixed-citation xml:lang="en">Poli L., Labella B., Cotti Piccinelli S. et al. Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy. Front Neurol. 2023;14:1242815. https://doi.org/10.3389/fneur.2023.1242815. PMID: 37869146; PMCID: PMC10585157.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nativi-Nicolau J. N., Karam C., Khella S., Maurer M. S. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness // Heart Fail Rev. 2022. Vol. 27, № 3. P. 785–793. https://doi.org/10.1007/s10741-021-10080-2. MID:33609196; PMCID: PMC9033715.</mixed-citation><mixed-citation xml:lang="en">Nativi-Nicolau J. N., Karam C., Khella S., Maurer M. S. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail Rev. 2022;27(3):785–793. https://doi.org/10.1007/s10741-021-10080-2. MID: 33609196; PMCID: PMC9033715.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kittleson M., Ruberg F., Ambardekar A. et al. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee // JACC. 2023. Vol. 81, № 11. P. 1076–1126.</mixed-citation><mixed-citation xml:lang="en">Kittleson M., Ruberg F., Ambardekar A. et al. 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee. JACC. 2023;81(11):1076–1126.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Koike H., Katsuno M. Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights // Biomedicines. 2019. Vol. 7, № 1. P. 11. https://doi.org/10.3390/biomedicines7010011. PMID: 30764529; PMCID: PMC6466231.</mixed-citation><mixed-citation xml:lang="en">Koike H., Katsuno M. Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights. Biomedicines. 2019;7(1):11. https://doi.org/10.3390/biomedicines7010011. PMID: 30764529; PMCID: PMC6466231.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sayed R. H., Rogers D., Khan F. et al. A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis // Eur Heart J. 2015. Vol. 36, № 18. P. 1098–105. https://doi.org/10.1093/eurheartj/ehu506. PMID: 25549725.</mixed-citation><mixed-citation xml:lang="en">Sayed R. H., Rogers D., Khan F. et al. A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis. Eur Heart J. 2015;36(18):1098–105. https://doi.org/10.1093/eurheartj/ehu506. PMID: 25549725.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Naharro A., Hawkins P. N., Fontana M. Cardiac amyloidosis // Clin Med (Lond). 2018. Vol. 18, Suppl 2. P. s30–s35. https://doi.org/10.7861/clinmedicine.18-2-s30. PMID: 29700090; PMCID: PMC6334035.</mixed-citation><mixed-citation xml:lang="en">Martinez-Naharro A., Hawkins P. N., Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018;18(Suppl 2):s30–s35. https://doi.org/10.7861/clinmedicine.18-2-s30. PMID: 29700090; PMCID: PMC6334035.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Maurer M. S., Schwartz J. H., Gundapaneni B. et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy // N Engl J Med. 2018. Vol. 379, № 11. P. 1007–1016. https://doi.org/10.1056/NEJMoa1805689. PMID: 30145929.</mixed-citation><mixed-citation xml:lang="en">Maurer M. S., Schwartz J. H., Gundapaneni B. et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016. https://doi.org/10.1056/NEJMoa1805689. PMID: 30145929.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
